304
Participants
Start Date
December 6, 2018
Primary Completion Date
May 13, 2025
Study Completion Date
May 13, 2025
DBV712 250 mcg
DBV712 250 mcg, once daily
Mount Sinai Medical Center, New York
University of Rochester, Rochester
UPMC Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Children's National Health Center, Washington D.C.
Johns Hopkins Hospital, Baltimore
The University of North Carolina - Chapell Hill, Chapel Hill
Children's Healthcare of Atlanta, Atlanta
Vanderbilt University Medical Center, Nashville
Le Bonheur Children's Hospital, Memphis
Riley Hospital for Children, Indianapolis
University of Michigan - Allergy Specialty Clinic and Food Allergy Clinic, Ann Arbor
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Comer Children's Hospital, Chicago
Arkansas Children's Hospital, Little Rock
Children's Medical Center Dallas, Dallas
Baylor College of Medicine, Houston
Dell Children's Medical Center of Central Texas, Austin
Children's Hospital Colorado, Aurora
David Geffen School of Medicine at University of California Los Angeles, Los Angeles
Rady Children's Hospital San Diego, San Diego
University of California San Francisco, San Francisco
Stanford University School of Medicine, Stanford
Seattle Allergy & Asthma Research Institute, Seattle
Banner University Medical Center Tucson, Tucson
Boston Childrens' Hospital, Boston
Lead Sponsor
DBV Technologies
INDUSTRY